SEC 13F Intelligence

Stephens Investment Management Group LLC / SUPN

Stephens Investment Management Group LLC’s Supernus Pharmaceuticals Position

Does Stephens Investment Management Group LLC own Supernus Pharmaceuticals (SUPN)? Yes — 1.35M shares worth $70M (+0.96% of its 13F portfolio) as of Q1 2026, down from 1.41M shares the prior filed quarter.

Position Value
$70M
Q1 2026
Shares
1.35M
% of Portfolio
+0.96%
Quarters Held
30
currently held

Position History SUPN

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $7MQ2 ’19: $10MQ3 ’19: $8MQ4 ’19: $7MQ4 ’19Q1 ’20: $5MQ2 ’20: $6MQ3 ’20: $6MQ4 ’20: $21MQ4 ’20Q1 ’21: $30MQ2 ’21: $38MQ3 ’21: $33MQ4 ’21: $46MQ4 ’21Q1 ’22: $52MQ2 ’22: $47MQ3 ’22: $54MQ4 ’22: $58MQ4 ’22Q1 ’23: $60MQ2 ’23: $51MQ3 ’23: $47MQ4 ’23: $55MQ4 ’23Q1 ’24: $65MQ2 ’24: $51MQ3 ’24: $60MQ4 ’24: $63MQ4 ’24Q1 ’25: $57MQ2 ’25: $50MQ3 ’25: $64MQ4 ’25: $70MQ4 ’25Q1 ’26: $70Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.35M$70M+0.96%
Q4 20251.41M$70M+0.91%
Q3 20251.35M$64M+0.83%
Q2 20251.58M$50M+0.66%
Q1 20251.74M$57M+0.82%
Q4 20241.75M$63M+0.85%
Q3 20241.93M$60M+0.82%
Q2 20241.90M$51M+0.71%
Q1 20241.90M$65M+0.86%
Q4 20231.90M$55M+0.81%
Q3 20231.70M$47M+0.77%
Q2 20231.70M$51M+0.80%
Q1 20231.66M$60M+1.01%
Q4 20221.60M$58M+1.04%
Q3 20221.61M$54M+1.03%
Q2 20221.61M$47M+0.86%
Q1 20221.60M$52M+0.76%
Q4 20211.58M$46M+0.59%
Q3 20211.24M$33M+0.45%
Q2 20211.25M$38M+0.53%
Q1 20211.14M$30M+0.43%
Q4 2020845.4K$21M+0.32%
Q3 2020298.6K$6M+0.11%
Q2 2020269.4K$6M+0.12%
Q1 2020280.9K$5M+0.12%
Q4 2019280.1K$7M+0.12%
Q3 2019286.2K$8M+0.16%
Q2 2019306.6K$10M+0.19%
Q1 2019210.1K$7M+0.15%
Q4 2018210.8K$7M+0.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stephens Investment Management Group LLC’s full portfolio or all institutional holders of SUPN.